ABEO — Abeona Therapeutics Inc · rev $20.1M

Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.

Latest reported ABEO revenue for 2026-06-30 was $20.1M. Net income was -$37.3M. ABEO currently screens at market cap $301.8M.

Use this ABEO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ABEO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ABEO SEC filings page. Lician reads the product cache first so this HTML stays unique to Abeona Therapeutics Inc even when a live quote feed is slow.

Abeona Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full ABEO income, balance, and cash tables.

  • Revenue$5.8M
  • Net Income$71.2M
  • Total Assets$219.6M
  • Total Debt$0
  • Free Cash Flow-$84.3M

ABEO recent filings